Tilray Brands, Inc. (NasdaqGS: TLRY)
Health Care · Pharmaceuticals · CA
$4.72
-2.48% today · -66.0% 1Y
Tilray Brands, Inc. (NasdaqGS: TLRY) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $640.10M and employs 3,595 people.
Over the last twelve months the share price has lost 66.0%, trading between 3.67 and 23.20.
Tweenvest scores Tilray Brands, Inc. across four factors: quality 45/100, value 76/100, growth 67/100. Its strongest factor is value.
TLRY price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $640.10M
- Revenue (TTM)
- $915.45M
- P/E
- —
- EPS
- -1.09
- Dividend yield
- —
- Beta (5Y)
- 1.92
- 52-week high
- $23.20
- 52-week low
- $3.67
- Avg volume (3M)
- —
- Shares outstanding
- 135.61M
- Employees
- 3,595
- Next earnings
- —
About Tilray Brands, Inc.
Tilray Brands, Inc. is a diversified global consumer packaged goods company primarily involved in the cultivation, processing, marketing, and sale of cannabis products. Its operations span a significant international footprint, encompassing Canada, the United States, Europe, Australia, New Zealand, and Latin America. The company organizes its business across four distinct divisions: Cannabis, Distribution, Beverage Alcohol, and Wellness. Within its cannabis division, Tilray provides a comprehensive range of medical and adult-use items, including regulated products like GMP-certified cannabis flowers, oils, vaporizers, edibles, and topical applications. Beyond cannabis, Tilray's portfolio extends to the procurement and resale of pharmaceutical and wellness goods. Furthermore, it manufactures, promotes, and distributes a variety of alcoholic beverages, alongside hemp-derived food and other wellness items. The company markets its diverse offerings under numerous recognized brands, such as Tilray, Aphria, SweetWater, and Breckenridge Distillery. Its products reach a wide array of customers, including retail outlets, wholesale partners, medical patients, healthcare practitioners, hospitals, pharmacies, scientific researchers, governmental bodies, and directly to end consumers. Formerly operating as Tilray, Inc., the corporation is headquartered in Leamington, Canada.
- ISIN
- US88688T2096
- Listed since
- Jul 19, 2018
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,246.93 | -0.67% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $273.04 | +1.04% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $150.66 | -1.24% |
| Roche Holding AGSWX: ROP | $368.80B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $27.97 | -0.36% |
Figures last refreshed Aug 18, 2026.